2020 Update of the quality indicators for acute myocardial infarction: a position paper of the Association for Acute Cardiovascular Care: the study group for quality indicators from the ACVC and the NSTE-ACS guideline group.


Journal

European heart journal. Acute cardiovascular care
ISSN: 2048-8734
Titre abrégé: Eur Heart J Acute Cardiovasc Care
Pays: England
ID NLM: 101591369

Informations de publication

Date de publication:
08 Apr 2021
Historique:
received: 27 11 2020
accepted: 10 12 2020
pubmed: 8 2 2021
medline: 25 11 2021
entrez: 7 2 2021
Statut: ppublish

Résumé

Quality indicators (QIs) are tools to improve the delivery of evidence-base medicine. In 2017, the European Society of Cardiology (ESC) Association for Acute Cardiovascular Care (ACVC) developed a set of QIs for acute myocardial infarction (AMI), which have been evaluated at national and international levels and across different populations. However, an update of these QIs is needed in light of the accumulated experience and the changes in the supporting evidence. The ESC methodology for the QI development was used to update the 2017 ACVC QIs. We identified key domains of AMI care, conducted a literature review, developed a list of candidate QIs, and used a modified Delphi method to select the final set of indicators. The same seven domains of AMI care identified by the 2017 Study Group were retained for this update. For each domain, main and secondary QIs were developed reflecting the essential and complementary aspects of care, respectively. Overall, 26 QIs are proposed in this document, compared to 20 in the 2017 set. New QIs are proposed in this document (e.g. the centre use of high-sensitivity troponin), some were retained or modified (e.g. the in-hospital risk assessment), and others were retired in accordance with the changes in evidence [e.g. the proportion of patients with non-ST segment elevation myocardial infarction (NSTEMI) treated with fondaparinux] and the feasibility assessments (e.g. the proportion of patients with NSTEMI whom risk assessment is performed using the GRACE and CRUSADE risk scores). Updated QIs for the management of AMI were developed according to contemporary knowledge and accumulated experience. These QIs may be applied to evaluate and improve the quality of AMI care.

Identifiants

pubmed: 33550362
pii: 6102821
doi: 10.1093/ehjacc/zuaa037
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

224-233

Informations de copyright

Published on behalf of the European Society of Cardiology. All rights reserved. © The Author(s) 2021. For permissions, please email: journals.permissions@oup.com.

Auteurs

François Schiele (F)

University Hospital Besancon, Boulevard Fleming, 25000 Besancon, France.

Suleman Aktaa (S)

University of Leeds, Leeds, UK.

Xavier Rossello (X)

Centro Nacional de Investigaciones Cardiovasculares (CNIC), Madrid, Spain.
Cardiology Department, Hospital Universitari Son Espases & Health Research Institute of the Balearic Islands (IdISBa), Palma, Spain.
CIBER de enfermedades CardioVasculares (CIBERCV), Madrid, Spain.

Ingo Ahrens (I)

Cardiology and Medical Intensive Care, Augustinerinnen Hospital Cologne, Cologne, Germany.

Marc J Claeys (MJ)

Antwerp University Hospital, Antwerp, Belgium.

Jean-Philippe Collet (JP)

Sorbonne Université, ACTION Study Group, Paris, France.
INSERM UMRS 1166, Institut de Cardiologie, Hôpital Pitié-Salpêtrière (AP-HP), Paris, France.

Keith A A Fox (KAA)

University and Royal Infirmary of Edinburgh, Edinburgh, UK.

Chris P Gale (CP)

University of Leeds, Leeds, UK.

Kurt Huber (K)

3rd Department of Medicine, Cardiology and Intensive Care Medicine, Wilhelminenhospital, Sigmund Freud University, Medical Faculty, Vienna, Austria.

Zaza Iakobishvili (Z)

Department of Community Cardiology, Clalit Health Services, Jaffa District, Tel Aviv, Israel.

Alan Keys (A)

Tonbridge, UK.

Ekaterini Lambrinou (E)

Department of Nursing, School of Health Sciences, Cyprus University of Technology, Limassol, Cyprus.

Sergio Leonardi (S)

University of Pavia and Fondazione IRCCS Policlinico S. Matteo, Pavia, Italy.

Maddalena Lettino (M)

Cardio-Thoracic-Vascular Department, San Gerardo Hospital, Monza, Italy.

Frederick A Masoudi (FA)

University of Colorado Anschutz Medical Campus, Aurora, CO, USA.

Susanna Price (S)

Royal Brompton & Harefield NHS Foundation Trust, Imperial College, London, UK.

Tom Quinn (T)

Kingston University & St. George's, University of London, London, UK.

Eva Swahn (E)

Linkoping University, Linkoping, Sweden.

Holger Thiele (H)

Department of Internal Medicine/Cardiology, Heart Center Leipzig at University of Leipzig, Leipzig, Germany.

Adam Timmis (A)

Barts Heart Centre and Queen Mary University London, London, UK.

Marco Tubaro (M)

San Filippo Neri Hospital, Rome, Italy.

Christiaan J M Vrints (CJM)

Antwerp University Hospital, Antwerp, Belgium.
University of Antwerp, Antwerp, Belgium.

David Walker (D)

East Sussex Healthcare NHS Trust, UK.

Hector Bueno (H)

CIBER de enfermedades CardioVasculares (CIBERCV), Madrid, Spain.
Cardiology Department, Hospital Universitario 12 de Octubre and Instituto de Investigación Sanitaria Hospital 12 de Octubre (imas12), Madrid, Spain.
Facultad de Medicina, Universidad Complutense de Madrid, Madrid, Spain.

Sigrun Halvorsen (S)

Department of Cardiology, Oslo University Hospital Ullevål, University of Oslo, Oslo, Norway.

Tomas Jernberg (T)

Department of Clinical Sciences, Danderyd Hospital, Karolinska Institutet, Stockholm, Sweden.

Jarle Jortveit (J)

Department of Cardiology, Sørlandet Hospital Arendal, Arendal, Norway.

Mai Blöndal (M)

Department of Cardiology, Tartu University, Estonia.

Borja Ibanez (B)

Department of Cardiology, Hospital Fundación Jiménez Díaz, Madrid, Spain.

Christian Hassager (C)

Department of Cardiology, Rigshospitalet, Copenhagen, Denmark.
Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH